/ Report Details / Induced Pluripotent Stem Cells (iPSCs) Market with COVID-19 Impact Analysis

Induced Pluripotent Stem Cells (iPSCs) Market with COVID-19 Impact Analysis, By Product (Automated Platforms, Consumables & Kits, Media, Kits, and Services), By Process, By Workflow, By End User, and By Region Size, Share & Forecast from 2022-2028

Report Code: AV1128

Industry: Healthcare

Publiced On: 2022-09-14

Pages: 306

Format: ppt pdf

REPORT HIGHLIGHT

Induced pluripotent stem cells (iPSCs) Market size was valued at USD 942.8 Million in 2021, growing at a CAGR of 8.2% from 2022 to 2028.

The creation of an endless source of any type of human cell required for therapeutic reasons is made possible by the invention of iPSC, which are created from skin or blood cells that have been reprogrammed to revert back to a pluripotent stage similar to that of an embryo. For instance, iPSC can be stimulated to develop into neurons to treat neurological illness, blood cells to make new blood devoid of cancer cells for a leukemia patient, or beta islet cells to cure diabetes.

Market Dynamics

The main factors influencing the market growth are the advantages that iPSCs offer when compared to ESCs. Compared to embryonic stem cells (ESCs), induced pluripotent stem cells have a number of advantages, including avoiding the ethical concerns surrounding stem cells and offering the greatest degree of versatility for use in cell-based research. In recent years, these benefits have given induced pluripotent stem cells (iPSCs) a lot of momentum, generating a favorable market for companies that operate in the sector. The market growth is expected to be accelerated by the strong pipeline for cell therapies derived from iPSCs and new iPSC applications. There are now 54 iPSC clinical studies underway as of 2021. For example, Allele Biotech is creating a diabetes medication from pancreatic beta cells produced from iPSCs.

Additionally, the growing acceptance of regenerative treatments is fostering market expansion. For the transplantation of tissue-specific cells to patients with various injuries, iPSCs are frequently employed. Additionally, scientists are interested in using iPSCs to expand different blood components ex vivo. Red blood cells produced from iPSCs have the potential to be used to create blood.

The research and development efforts based on iPSCs have expanded due to the COVID-19 pandemic. Researchers are also eager to develop novel medications and treatments to fight this epidemic. In this situation, iPSCs are effective research resources for creating normal, relevant cell types for SARS-CoV-2. iPSCs are crucial for creating physiologically accurate human-cell models that can mimic the pathophysiology of COVID-19, as well.

Segmentation Analysis:

The Global Induced pluripotent stem cells (iPSCs) Market is segmented on the basis of Product, Process, Workflow, End User, and Region.

The market is divided into nine categories based on process type: Manual Process, Automated Process. The manual Production Process held the majority of the market share of nearly 81.2% in terms of revenue. By merely improving the manual methods that are regularly employed to reprogramme patient cells, the iPSC production process can be made to be both affordable and effective. Automated platforms are expected to register the fastest growth of 8.3% of the Induced pluripotent stem cells (iPSCs) market. Automated platforms are recognized to generate iPSCs that are more trustworthy, eliminating human bias and assuring protocol uniformity.

The market is divided into two categories based on application: Reprogramming, Cell Culture, Cell Characterization/Analysis, Engineering, and Others. The cell Culture segment accounted for the largest share over 32.3% in 2021 of the Induced pluripotent stem cells (iPSCs) market 2021. Over the forecast period, it is expected to grow at a constant CAGR. Cell culture is a common procedure for creating iPSCs since studying stem cell activity and differentiation during development is difficult, expensive, and time-consuming.

Competitive Landscape:

The global market for Induced pluripotent stem cells (iPSCs) is made of a number of both international and local producers, making it a fairly competitive sector in the world. Some of the leading strategies adopted by corporations to expand their market share include new product launches, agreements, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2021, Evotec SE received USD 6 million from Bristol Myers Co. for their iPS cell-based neuroscience partnership. In addition, Axol Biosciences introduced Multi-Electrode Array (MEA) screening for human iPSC-derived cells in October 2020. This initiative will impact positively on the market development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET KEY PLAYERS

  • Lonza
  • Axol Biosciences Ltd.
  • Evotec
  • Hitachi Ltd.
  • Merck KGaA
  • REPROCELL, Inc.
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • StemCellFactory III
  • Applied StemCell, Inc

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY PRODUCT TYPE

  • Automated Platforms
  • Consumables & Kits
  • Media
  • Kits
  • Services

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY PROCESS

  • Manual
  • Automated

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY WORKFLOW

  • Reprogramming
  • Cell Culture
  • Cell Characterization/Analysis
  • Engineering
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY END-USER

  • Research & Academic Institutes
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & clinic

GLOBAL INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT

1. Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Product Type
2.1.2. Market Snippet by Process
2.1.3. Market Snippet by Workflow
2.1.4. Market Snippet by End User
2.1.5. Market Snippet by Country
2.1.6. Market Snippet by Region
2.2. Competitive Insights
3. Induced Pluripotent Stem Cells (iPSCs) Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Induced Pluripotent Stem Cells (iPSCs) Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Induced Pluripotent Stem Cells (iPSCs) Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Induced Pluripotent Stem Cells (iPSCs) Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Induced Pluripotent Stem Cells (iPSCs) Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2021 & 2028 (%)
7.1.2. Automated Platforms
7.1.3. Consumables & Kits
7.1.4. Media
7.1.5. Kits
7.1.6. Services
8. Induced Pluripotent Stem Cells (iPSCs) Market – By Process
8.1. Overview
8.1.1. Segment Share Analysis, By Process, 2021 & 2028 (%)
8.1.2. Manual
8.1.3. Automated
9. Induced Pluripotent Stem Cells (iPSCs) Market – By Workflow
9.1. Overview
9.1.1. Segment Share Analysis, By Workflow, 2021 & 2028 (%)
9.1.2. Reprogramming
9.1.3. Cell Culture
9.1.4. Cell Characterization/Analysis
9.1.5. Engineering
9.1.6. Others
10. Induced Pluripotent Stem Cells (iPSCs) Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2021 & 2028 (%)
10.1.2. Research & Academic Institutes
10.1.3. Biotechnology & Pharmaceutical Companies
10.1.4. Hospitals & clinic
11. Induced Pluripotent Stem Cells (iPSCs) Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
11.2. North America
11.2.1. Overview
11.2.2. Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.2.5. North America Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.2.6. North America Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.2.8.
11.2.9. U.S.
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.2.9.3. U.S. Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.2.9.4. U.S. Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.2.9.5. U.S. Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.2.9.6. U.S. Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.2.10. Canada
11.2.10.1. Overview
11.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.2.10.3. Canada Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.2.10.4. Canada Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.2.10.5. Canada Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.2.10.6. Canada Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.5.12.5. Colombia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Process, 2017 - 2028 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Workflow, 2017 - 2028 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
12. Key Vendor Analysis
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Lonza
12.2.2. Axol Biosciences Ltd.
12.2.3. Evotec
12.2.4. Hitachi Ltd.
12.2.5. Merck KGaA
12.2.6. REPROCELL, Inc.
12.2.7. Fate Therapeutics
12.2.8. Thermo Fisher Scientific, Inc.
12.2.9. StemCellFactory III
12.2.10. Applied StemCell, Inc
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights